Grants
Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed) (RFA-TR-25-002)
Sponsor
National Center for Advancing Translational Sciences
Award
The combined budget for direct costs for the two-year project period may not exceed $275,000. No more than $200,000 may be requested in any single year.
Due Date
June 02, 2025 (Letter of Intent due May 1, 2025) or June 02, 2026 (Letter of Intent due May 1, 2026).